Navigating Weight Loss Drugs: Industry vs. Patient Needs

This chapter examines the disconnect between pharmaceutical companies' objectives for weight loss and the actual experiences of patients in clinical trials. It discusses the health risks associated with rapid weight loss, including potential complications from powerful medications and the implications of protocol changes in drug trials. Through interviews and expert insights, the chapter questions whether corporate priorities truly align with patient health and safety.